| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 08/01/2006 | US7083967 Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation |
| 08/01/2006 | US7083966 Gene ecodeing protein; activation; cloning cloningDna libraries from rodents |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083962 Carbonyl reductases, polynucleotides comprising DNA encoding the same, methods for producing the same, and methods for producing optically active alcohol utilizing the same |
| 08/01/2006 | US7083960 Amino acid substitutions which result in reduced hydrophobicity; use in oxidizing the terminal methyl group of a substrate to a carboxylic acid |
| 08/01/2006 | US7083952 Nucleotide sequences coding phosphoserine phosphatase for generation of trangenic cornyeform bacterium with enhanced serine and threonine biosynthesis; for use in preparation of food, animal feeds and/or human therapeutics |
| 08/01/2006 | US7083951 Flow cytometric detection method for DNA samples |
| 08/01/2006 | US7083950 Isolated nucleic acids; binding to immunoglobulins |
| 08/01/2006 | US7083949 Receptor based antagonists and methods of making and using |
| 08/01/2006 | US7083946 Comprises nucleotide sequences coding membrane protein for use in the treatment, diagnosis and prevention of cell proliferative, nervous system, autoimmune and cardiovascular disorders |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083935 Androgen receptor complex-associated protein |
| 08/01/2006 | US7083931 Polypeptides; green fluorescent protein ; genetic engineering |
| 08/01/2006 | US7083930 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 08/01/2006 | US7083929 Automatic sequencing kits |
| 08/01/2006 | US7083928 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
| 08/01/2006 | US7083927 Comprises nucleotide sequences coding ubiquitin protein ligase complex polypeptides for diagnosid and treatment of cancer, immune/inflammatory and neurological disorders |
| 08/01/2006 | US7083923 High-throughput glutathione S-transferase polymorphic allele assay design |
| 08/01/2006 | US7083922 Via oligonucleotide probes which hybridize with HIV nucleic acids and are amplified via reverse transcriptase |
| 08/01/2006 | US7083921 Method to determine the risk for side effects of an SSRI treatment in a person |
| 08/01/2006 | US7083917 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 08/01/2006 | US7083915 Polycystic kidney disease PKD2 gene and uses thereof |
| 08/01/2006 | US7083511 Activation of tyrosine kinase by phosphorylation |
| 08/01/2006 | CA2341263C Enzyme inhibition immunoassay |
| 08/01/2006 | CA2265485C Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 08/01/2006 | CA2192073C Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 08/01/2006 | CA2165435C Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 07/27/2006 | WO2006078746A2 Method, compositions and classification for tumor diagnostics and treatment |
| 07/27/2006 | WO2006078256A2 Polypeptides having xylanase activity and polynucleotides encoding same |
| 07/27/2006 | WO2006036916A3 Rnai modulation of apob and uses thereof |
| 07/27/2006 | WO2006028497A3 Active recombinant human lysozyme |
| 07/27/2006 | WO2006023491A3 Method of delivering rna interference and uses thereof |
| 07/27/2006 | WO2006014798A3 Methods and compositions for using sax2 |
| 07/27/2006 | WO2006012440A3 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| 07/27/2006 | WO2005118872A3 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases |
| 07/27/2006 | WO2005111057A3 Immunostimulatory nucleic acids for inducing il-10 responses |
| 07/27/2006 | WO2005110459A3 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 07/27/2006 | WO2005086813A3 Glutamine-rich maize seed protein and promoter |
| 07/27/2006 | WO2005060675A3 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/27/2006 | WO2004106360A3 Viral vectors with improved properties |
| 07/27/2006 | WO2004094614A3 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 07/27/2006 | WO2004074456A3 Methods for selecting medications |
| 07/27/2006 | WO2004053081A3 Compositions, splice variants and methods relating to prostate specific genes and proteins |
| 07/27/2006 | WO2004034988A3 Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors |
| 07/27/2006 | US20060168696 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass and other characteristics |
| 07/27/2006 | US20060168687 Expression vector comprising nucleotide sequences coding acyl-CoA:lysophospholipid-acyltransferase for enhancing production of dihmo-gama-linolenic, arachidonic, eisosapentaenoic, docosapentaenoic acid and/or docosahexaenoic acids |
| 07/27/2006 | US20060168682 Plant peptide with antimicrobial activity |
| 07/27/2006 | US20060168679 Transgenic rice plant |
| 07/27/2006 | US20060168675 Novel polypetide having function of 7-keto-8-aminopelargonic acid synthase of plant and method for inducing growth inhibition and lethality by suppressing expression of the polypeptide |
| 07/27/2006 | US20060168673 Transgenic animals as models for neurodegenerative disease |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168670 identification of new gene families that are differentially expressed in cancerous human tissues compared to normal human tissues; useful as diagnostic agents or markers to detect cancer or to differentiate carcinoma from normal tissue in a sample; nucleotide sequence |
| 07/27/2006 | US20060168668 Phosphodiesterase 2a and methods of use |
| 07/27/2006 | US20060167241 Method for synthesizing cyclic bisdinucleoside |
| 07/27/2006 | US20060167240 compounds comprising a phosphoramidite moiety and a protecting group bonded to a linker chain, and reporter group bonded to the protecting group, used for the functionalization, derivatization and modification that can be introduced into nucleotides |
| 07/27/2006 | US20060167239 Compounds and processes for single-pot attachment of a label to siRNA |
| 07/27/2006 | US20060167238 Gene expression using metal ion dependent repressor/operator tandems |
| 07/27/2006 | US20060167231 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2006 | US20060167228 Sequences from an endosymbiont and their uses |
| 07/27/2006 | US20060167226 Mutations of voltage-gated ion channnels that allow them to express a voltage-independent phenotype and an improved method to use the same |
| 07/27/2006 | US20060167225 Novel fluorescent protein from aequorea coerulscens and methods for using the same |
| 07/27/2006 | US20060166922 Polynucleotides targeted against the extended 5'-UTR region of argininosuccinate synthase and uses thereof |
| 07/27/2006 | US20060166918 chemically modified oligonucleotides; double stranded iRNA agent; comprising a cholesterol moiety; increased stability in a biological sample |
| 07/27/2006 | US20060166915 Human coagulation factor VII polypeptides |
| 07/27/2006 | US20060166913 Process for producing sirna |
| 07/27/2006 | US20060166912 Use of cytochrome p450 enzyme cyp2w1 as a drug target for cancer theraphy |
| 07/27/2006 | US20060166909 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof |
| 07/27/2006 | US20060166908 Nucloeside analogues and oligonucleotide derivative comprising nucleotide analogue thereof |
| 07/27/2006 | US20060166874 Fvii or fviia variants having increased clotting activity |
| 07/27/2006 | US20060166363 Modified baculovirus expression system for production of pseudotyped rAAV vector |
| 07/27/2006 | US20060166338 Alleles of the mqo gene from coryneform bacteria |
| 07/27/2006 | US20060166331 Pharmaceutical grade manufacture of quality plasmid DNA from cell lysates using flotation to separate and eliminate undesired insoluble cellular debris including chromosomal DNA from the lysates |
| 07/27/2006 | US20060166329 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin |
| 07/27/2006 | US20060166328 IGF-I fusion polypeptides and therapeutic uses thereof |
| 07/27/2006 | US20060166327 G-protein chemokine receptor; use in drug screening and diagnosis of conditions related to the underexpression of the G-protein coupled receptor polypeptides by detecting a mutation |
| 07/27/2006 | US20060166326 Fusion proteins; host cells |
| 07/27/2006 | US20060166325 Glial cell line-derived neurotrophic factor receptor |
| 07/27/2006 | US20060166324 Screening tools for discovery of novel anabolic agents |
| 07/27/2006 | US20060166322 Cellulases; beta-glucosidases; hydrolases; conversion of cellulose to sugars and/or ethanol; laundry detergents |
| 07/27/2006 | US20060166320 In vitro expression of the HCV ARFP/F-core‘coding open reading frame |
| 07/27/2006 | US20060166318 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles |
| 07/27/2006 | US20060166317 Nucleic acids encoding sialytransferases from C. jejuni |
| 07/27/2006 | US20060166316 Phosphodiesterase 10a7 isoforms and methods of use |
| 07/27/2006 | US20060166315 Process for producing pnpase |
| 07/27/2006 | US20060166314 Method for rational mutagenesis of alpha/beta t-cell receptors and correspondingly mutated mdm2-protein specific alpha/beta t-cell ceceptores |
| 07/27/2006 | US20060166313 Novel glycero kinase, gene thereof and process for producing the glycerol kinase by using the gene |
| 07/27/2006 | US20060166311 Novel notch-origin polypeptides and biomarkers and reagents using the same |
| 07/27/2006 | US20060166310 Serotonin receptor |
| 07/27/2006 | US20060166309 Novel G-protein coupled receptors |
| 07/27/2006 | US20060166304 Polynucleotides encoding insect 3-ketosphinganine reductase and uses thereof |
| 07/27/2006 | US20060166282 Methods and compositions for screening cell binding molecules |
| 07/27/2006 | US20060166275 Amyloid beta protein (globular assembly and uses thereof) |
| 07/27/2006 | US20060166274 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2006 | US20060166265 Survivin-binding proteins, encoding nucleic acids, and methods of use |
| 07/27/2006 | US20060166259 APM1 biallelic markers and uses thereof |
| 07/27/2006 | US20060166258 Preservation of RNA in a biological sample |
| 07/27/2006 | US20060166256 IL-1 receptor accessory protein |
| 07/27/2006 | US20060166248 Fluorescent N2, N3-etheno-purine (2'deoxy) riboside derivatives and uses thereof |
| 07/27/2006 | US20060166246 Detection of fungal pathogens using the polymerase chain reaction |
| 07/27/2006 | US20060166244 DNA markers for increased milk production in cattle |